LAG3 and neoplasm: Within the tumor microenvironment, Gal-3, via LAG-3 expression, inhibits the activation of antigen-specific CD8+ T cells and suppresses the expansion of plasmacytoid DCs, thereby impeding the formation of an effective anti-tumor immune response (144).